CXCL12-(1-17) [2553]
CXCL12-(1-17)
| SMILES | CC(C)CC(NC(=O)C(CO)NC(=O)C(NC(=O)C1CCCN1C(=O)C(N)CCCCN)C(C)C)C(=O)NC(CO)C(=O)NC(Cc1ccc(O)cc1)C(=O)NC(CCCN=C(N)N)C(=O)NC(CS)C(=O)N1CCCC1C(=O)NC(CS)C(=O)NC(CCCN=C(N)N)C(=O)NC(Cc1ccccc1)C(=O)NC(Cc1ccccc1)C(=O)NC(CCC(=O)O)C(=O)NC(CO)C(=O)NC(Cc1c[nH]cn1)C(=O)O |
| InChIKey | UQMATGKUTLWKOZ-UHFFFAOYSA-N |
| Sequence | KPVSLSYRCPCRFFESH |
| HELM | PEPTIDE1{K.P.V.S.L.S.Y.R.C.P.C.R.F.F.E.S.H}$$$$ |
Chemical Properties
| Hydrogen bond acceptors | None |
| Hydrogen bond donors | None |
| Rotatable bonds | None |
| Log P | None |
| Molecular weight (Da) | None |
Database connections
|
|
No bioactivity data available.
CXCL12-(1-17)
Drug properties
| Molecular type | Peptide |
| Physiological/Surrogate | Surrogate |
| Approved drug | No |
Distribution across phases (no. indications)
Phase I
0
Phase II
0
Phase III
0
Phase IV
0
Database connections
|
|